Диссертация (1139893), страница 15
Текст из файла (страница 15)
Med. Assoc. J. – 2005. – Vol.173. – P.627-634.119. Dynamic cardiovascular risk assessment in elderly people. The role ofrepeated N-terminal pro-B-type natriuretic peptide testing [Теxt] / C.R. deFilippi [et al.] // J Am Coll Cardiol. 2010. Vol. 55. P. 441–450.120. Elnoamany, M.F. Mitral annular motion as a surrogate for left ventricularfunction: correlation with brain natriuretic peptide levels [Теxt] / M.F.Elnoamany, A.K. Abdelhameed // Eur. J. Echocardiogr. 2006.
Vol.7. P. 187–198.121. Estimation of right ventricular volume by modified echocardiographicsubtraction method [Теxt] / M. Tomita [et al.] // Am. Heart J. 1992. Vol. 123. P. 1011.103122. Fleisher, Lee A. Implications of Preoperative Heart Failure: The NextFrontier in Perioperative Medicine? [Теxt] / Lee A. Fleisher //Anesthesiology.
2008. Vol. 108, № 4. P. 551552.123. Fleisher L.A., Fleishmann K.E., Auerbaeh et al. 2014. ACC/AHA guidelineon perioperative cardiovascular evaluation and management of patientsundergoing noncardiac surgery: executive summary: a report of theAmerican College of Cardiology/American Heart Association Task Force onpractice guidelines // Circulation. – 2014. – Vol.130 (24). – P.2215-45.124. Goetze, J. Increased cardiac BNP expression associated with myocardialischemia [Теxt] / J. Goetze, C.
Christoffersen, M. Perko // FASEB J. 2003. Vol. 17, № 9. P. 11051107.125. Goldman, L. Assessment of Perioperative Cardiac Risk [Теxt] / L. Goldman// N. Engl. J. Med. 1994. Vol. 330, № 10. P. 707709.126. Grocott, M.P. Perioperative fluid management and clinical outcomes inadults [Теxt] / M.P. Grocott, M.G.
Mythen, T.J. Gan // Anesth. Analg. 2005. Vol. 100, № 4. P. 10931096.127. Hall, C. Essential biochemistry and physiology of NT-pro-BNP [Теxt] / C.Hall // European Journal of Heart Failure. 2004. № 6. P. 257260.128. Heart rate variability and the prone position under general versus spinalanesthesia [Теxt] / J.E. Tetzlaff [et al.] // J. Clin.
Anesth. 1998. Vol. 10,№ 2. P. 133136.129. Hickey, S. Cardiovascular response to insertion of Brain’s laryngeal mask[Теxt] / S. Hickey, A.E. Cameron, A.J. Asbury // Anaesthesia. 1990. Vol. 45, № 8. P. 629633.130. Huikuri, H.V. Alterations in heart rate variability and its circadian rhythm inhypertensive patients with left ventricular hypertrophy free of coronary arterydisease [Теxt] / H.V.
Huikuri, J.O. Valkama, K.E. Airaksinen //Circulation. 1993. Vol. 87. P. 12201228.104131. Immediately postoperative B-type natriuretic peptide and its predictive value[Теxt] / S. Suttie [et al.] // Ann Vasc Surg. 2011. Vol. 25(2). P. 248255.132. Impact of Heart Failure on Patients Undergoing Major Noncardiac Surgery[Теxt] / H. Bradley [et al.] // Anesthesiology. 2008.
Vol. 108, № 4. P. 559567.133. Influence of renal function on the usefulness of N-terminal pro-B-type natriureticpeptide as a prognostic cardiac risk marker in patients undergoing noncardiacvascular surgery [Теxt] / D. Goei [et al.] // Am J Cardiol. 2008. Vol.101. P. 122–126.134. Intraoperative Tachycardia and Hypertension Are Independently Associatedwith Adverse Outcome in Noncardiac Surgery of Long Duration [Теxt] /L.R. David [et al.] // Anesth. Analg. 2002.
Vol. 95, № 2. P. 273277135. Justin P. Wagner. B-Type Natriuretic Peptide for the Evaluation of VolumeStatus in Elderly Postoperative Patients [Теxt] / Justin P. Wagner, JonathanR. Hiatt.//JAMA.2014.Vol.311(19).P. 20172018.136. Levine, W.C. Anesthesia for the elderly: selected topics [Теxt] / W.C.Levine, V. Mehta, G. Landesberg // Curr. Opin. Anaesthesiol. 2006. Vol. 19, № 3. P. 320324.137.
Lubien, E. Utility ofB-natriuretic peptide in diagnosing diastolicdisfunction [Теxt] / E. Lubien, A. DeMaria // Circulation. 2002. Vol.105. P. 595601.138. Mahla, Е. B-type natriuretic peptide in high-risk major surgery patients[Теxt] / Е. Mahla, M. Vicenzi, W. Toller // Br. J. Anaesth. 2007. Vol.99, № 5. P. 746747.105139. Mangano, D.T. Analysis of heart rate variability [Теxt] / D.T.
Mangano, M.G.Wong, M. J. London // J. Amer. Clin. Cardiol. 1991. Vol. 17. P. 843850.140. McCrae, A.F. Prevention and treatment of hypotension during central neuralblock [Теxt] / A.F. McCrae, J.A. Wildsmith // Br. J. Anaesth. 1993. Vol. 70. P. 672–680.141. Mitka, M. Peptides Prove Predictive for Heart Failure Patients [Теxt] / M.Mitka // JAMA. 2002. Vol. 287, № 15. P. 19261929.142. Motwani, J. Plasma BNP as an indicator for angiotensin converting enzymeinhibition after myocardial infarction [Теxt] / J. Motwani, H. McAlpine,N. Kennedy // Lancet.
1993. Vol. 341. P. 11091113.143. N-Terminal fragment of the progormon Bain-Type natriuretic peptide (NT-proBNP), cardiovascular events, and mortality in patient with stabl coronary heartdisease [Теxt] / K. Bibbins-Domingo [et al.] // JAMA. 2007. Vol. 297. № 2. P.
169176.144. N-terminal pro-b-type natriuretic peptide and left atrial function in patientswith congestive heart failure and severely reduced ejection fraction [Теxt] /M. Prastaro [et al.] // Eur. J. Echocardiogr. 2011. Vol. 12, № 7. P. 506513.145. N-terminal pro-B-type natriuretic peptide levels for dynamic riskstratification of patients with acute coronary syndromes [Теxt] / C.N.Heeschen [et al.] // Circulation.
2004. Vol. 110. P. 3206–3212.146. New understanding of the heart structure and function [Теxt] / F. TorrentGuasp [et al.] // Eur. J. Cardiothorac. Surg. 2005. Vol. 27, № 2. P. 191–201.147. Nishikimi T. Relationship between left ventricular geometry and natriureticpeptide levels in essential hypertension [Теxt] / T. Nishikimi, F. Yoshihara,M. Atsushi // Hypertention.
1996. Vol. 28. P. 2230.106148. NT-proBNP: a new diagnostic screening tool to differentiate betweenpatients with normal and reduced left ventricular systolic function [Теxt] /M. Bay [et al.] // Heart. 2003. Vol. 89. Р. 150154.149. NT-proBNP and the diagnosis of heart failure [Теxt] / T.A. McDonagh [etal.] // European Journal of Heart Failure. 2004. № 6. P.
269273.150. Omland, T. Nt-pro-BNP natriuretic peptide and long-term mortality in acutecoronary syndromes [Теxt] / T. Omland, A. Persson, R. O’ Brien //Circulation. 2002. Vol. 106. P. 2913.151. Optimal noninvasive assessment of left ventricular filling pressures: acomparison of tissue Doppler echocardiography and B-type natriureticpeptide in patients with pulmonary artery catheters [Теxt] / H. Dokainish [etal.] // Circulation. 2004. Vol. 109(20).
P. 24322439.152. Oscarsson, A. N-terminal fragment of pro-B-type natriuretic peptide is apredictor of cardiac events in high-risk patients undergoing acute hipfracture surgery [Теxt] / A. Oscarsson, M. Fredrikson, M. Sorliden // Br. J.Anaesth. 2009. Vol. 103, № 2. P. 206212.153. Payne, C.J. B-type natriuretic peptide predicts long-term survival after majornon-cardiac surgery [Теxt] / C.J. Payne, S.C. Gibson, G. Bryce // Br.
J.Anaesth. 2011. Vol. 107, № 2. P. 144149.154. Perel, A. Cardiovascular effects of mechanical ventilation [Теxt] / A. Perel,R. Pizov // Mechanical ventilator support. Baltimore: Williams andWilkins, 1994. P. 5165.155. Plasma natriuretic peptide levels and the risk of cardiovascular events anddeath [Теxt] / T.J.
Wang [et al.] // N Engl J Med. 2004. Vol. 350. P. 655–63.156. Prognostic value of Brain Natiuretic Peptide in acute heart failure: mortalità andhospital redmission [Теxt] / J. Nunez [et al.] // Rev Esp. Cardiol. 2008. Vol. 61. P. 1332–1337.107157. Prognostic value of brain natriuretic peptide in noncardiac surgery: a metaanalysis [Теxt] / A.D.S. Ryding [et al.] // Anesthesiology. 2009. Vol.111. P. 311–320.158. Prys-Roberts, C.
Perioperative cardiac risk [Теxt] / C. Prys-Roberts, S.Howell // Br. J. Anaesth. 2004. Vol. 93, № 5. P. 745–746.159. Rich, M.W. Epidemiology, pathophysiology and etiology of congestiveheart failure in older adults [Теxt] / M.W. Rich // J. Am. GeriatricsSociety. 1997. Vol. 45. P. 968.160. Ronald, J. Laboratory and Clinical Aspects of B-Type Natriuretic Peptides[Теxt] / J.
Ronald, E. William, Е. Winter // Archives of Pathology andLaboratory Medicine. 2004. Vol. 128, № 6. P. 697–699.161. Rothenburger, M. Aminoterminal pro type B natriuretic peptide as apredictive and prognostic marker in patients with chronic heart failure [Теxt]/ M. Rothenburger, T.
Wichter, C. Schmid // J. Heart Lung Transplant. 2004. Vol. 23, № 10. P. 11891197.162. Sahiman, L. Myocardial circulatory and metabolic effects of halothane whenused to control intraoperative hypertension in patients with coronary arterydisease [Теxt] / L. Sahiman, I.
Milocco, S.E. Ricksten // J. Cardiothorac.Anesth. 1989. Vol. 3, № 5. Suppl. 1. P. 7.163. Scharhag, J. N-terminal B-type natriuretic peptide concentrations aresimilarly increased by 30 minutes of moderate and brisk walking in patientswith coronary artery diseas [Теxt] / J.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
